Si. Nishikawa et S. Nishikawa, Monoclonal antibody-mediated manipulation as a tool for dissecting geneticpathways underlying specific embryonic processes, PIGM CELL R, 14(4), 2001, pp. 249-255
The technology to produce monoclonal antibody (mAb) is one of mainstays sup
porting current biology. Identification and isolation of a specific molecul
e in situations where many other molecules coexist is the most popular way
of using this technology. Some mAb can trigger or suppress the function of
a given molecule, thus having a potential for use in manipulating developme
ntal processes. A decade ago, we demonstrated that embryonic components of
pigment cell development could be manipulated by injection of a mAb that in
hibits the function of the c-Kit tyrosine kinase receptor (RTK) into pregna
nt mice. While we believe that no other methods were available at that time
to freely trigger or suppress the function of such molecules as c-Kit, mol
ecular genetic technologies enabling the same task have been developed rece
ntly.
In this article, we want to give a general overview of our previous experie
nce of using mAb for manipulating embryonic processes, and discuss the pote
ntial of this technology in the age of new molecular genetics.